✦ LIBER ✦

Sa1086 Adalimumab or Infliximab for the Treatment of Inflammatory Bowel Disease Patients: Which Is More Effective?

✍ Scribed by Carrillo-Ramos, Maria Jesus; Duarte-Chang, Calixto; Maldonado-Perez, Belen; Beltran-Castaño, Rocio; Castro-Laria, Luisa; Argüelles-Arias, Federico; Benitez-Roldan, Antonio; Caunedo-Alvarez, Angel; Pellicer-Bautista, Francisco; Herrerias, Juan M

Book ID: 122136750
Publisher: Elsevier Science
Year: 2014
Tongue: English
Weight: 148 KB
Volume: 146
Category: Article
ISSN: 0016-5085
DOI: 10.1016/S0016-5085(14)60690-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

P042 The effect of infliximab and adalim

P042 The effect of infliximab and adalimumab treatment on angiogenic factor levels in patients with inflammatory bowel disease (IBD)

✍ A. Algaba; P.M. Linares; M.E. Fernández-Contreras; A. Figuerola; X. Calvet; I. G 📂 Article 📅 2012 🏛 Oxford University Press 🌐 English ⚖ 51 KB

Tu1886 The Effect of Infliximab and Adal

Tu1886 The Effect of Infliximab and Adalimumab Treatment on Angiogenic Factor Levels in Patients With Inflammatory Bowel Disease (IBD)

✍ Algaba, Alicia; Linares, Pablo M.; Fernandez Contreras, Maria Encarnacion; Figue 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 109 KB

Sa2034 Early Discontinuation of Inflixim

Sa2034 Early Discontinuation of Infliximab During Pregnancy Reduces Neonatal Exposure to Infliximab and is Safe for the Inflammatory Bowel Disease Patients

✍ Zelinkova, Zuzana; van der Ent, Cokkie; Bruin, Karlien F.; van Baalen, Onno; Ver 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 82 KB

Microalbuminuria is a good predictor whi

Microalbuminuria is a good predictor which evaluates the responses of treatment in patients with inflammatory bowel disease

✍ Higa, A.; Kiyomizu, A.; Kitani, M.; Sakata, J.; Eto, T. 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 155 KB

Anti-nuclear antibody positivity and the

Anti-nuclear antibody positivity and the use of certolizumab in inflammatory bowel disease patients who have had arthralgias or lupus-like reactions from infliximab or adalimumab

✍ Himanshu Dev VERMA; Ellen Janice SCHERL; Vinita Elizabeth JACOB; Brian Paul BOSW 📂 Article 📅 2011 🏛 Wiley (Blackwell Publishing) 🌐 English ⚖ 195 KB

Sa1242 The Use of IVIG in IBD Patients W

Sa1242 The Use of IVIG in IBD Patients With Contraindications or Who Are Unresponsive to Conventional Treatment for Inflammatory Bowel Disease

✍ Merkley, Scott A.; Horst, Sara N.; Beaulieu, Dawn B.; Duley, Caroline; Annis, Ki 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 107 KB